Diabetes insipidus occurs as a result of vasopressin deficiency (antidiuretic hormone caused by a hypothalamic-pituitary disorder, which is known as central diabetes insipidus) or by resistance of the kidneys to vasopressin (nephrogenic diabetes insipidus). The disease is primarily characterized by polyuria (abundant urine excretion) and polydipsia (pathological need to drink water) and is confirmed by...
AllCardiovascularChild DevelopmentCuba’s AchievementsCubaHeal NewsDermatologyEducationEndocrinologyGeriatricGynecologyInternational CollaborationMedical (General)NeurologyOncologyOphthalmologyOrthopedicPsychiatrySubstance Abuse RehabilitationTravel InsuranceUncategorized
CubaHeal Research Department A lifetime risk for a diabetic ulcer in patients suffering from diabetes type 1 or 2 is approximated to 25%,meaning that every fourth person with diabetes will develop diabetic ulcer (1) . Diabetic foot ulcersrepresent a medically significant disease complication, with a high incidence of morbidity and mortalityin the modern world. Risks...
For Diabetic Foot Ulcer, Heberprot-P is a drug developed by the Center for Genetic Engineering and Biotechnology (CIGB) in 2007 in Cuba. Diabetes is no longer considered life threatening, nonetheless diabetes and complications due to diabetes, when not under control, remain to be sixth leading cause of death having a higher mortality rate than some...